Singapore markets closed

AVROBIO, Inc. (AVRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2100+0.0250 (+2.11%)
As of 01:34PM EDT. Market open.
Full screen
Loading interactive chart…
  • Business Wire

    AVROBIO and Tectonic Therapeutic Announce Merger

    CAMBRIDGE, Mass. & WATERTOWN, Mass., January 30, 2024--AVROBIO, Inc. (Nasdaq: AVRO) and Tectonic Therapeutic, Inc. ("Tectonic"), a privately-held biotechnology company developing GPCR (G-protein coupled receptor)-targeted therapeutic proteins, co-founded by Timothy A. Springer and Andrew C. Kruse of Harvard Medical School, today announced that the companies have entered into a definitive merger agreement to combine in an all-stock transaction (the "Merger"). Under the terms of the agreement, AVR

  • Zacks

    Is AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?

    Here is how AVROBIO, Inc. (AVRO) and Crinetics Pharmaceuticals, Inc. (CRNX) have performed compared to their sector so far this year.

  • Zacks

    Is AVROBIO (AVRO) Outperforming Other Medical Stocks This Year?

    Here is how AVROBIO, Inc. (AVRO) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.